Pavla Bouchalová

420 total citations
16 papers, 283 citations indexed

About

Pavla Bouchalová is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Pavla Bouchalová has authored 16 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Pavla Bouchalová's work include Advanced Proteomics Techniques and Applications (3 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related Molecular Pathways (3 papers). Pavla Bouchalová is often cited by papers focused on Advanced Proteomics Techniques and Applications (3 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related Molecular Pathways (3 papers). Pavla Bouchalová collaborates with scholars based in Czechia, United Kingdom and United States. Pavla Bouchalová's co-authors include Pavel Bouchal, Bořivoj Vojtěšek, Roman Hrstka, Petr Müller, Philip J. Coates, Rudolf Nenutil, Eva Matoulková, Eva Michalová, Marta Nekulová and Jitka Holčáková and has published in prestigious journals such as Scientific Reports, Nanoscale and The Journal of Pathology.

In The Last Decade

Pavla Bouchalová

16 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavla Bouchalová Czechia 9 160 93 72 60 35 16 283
Victoria M.-Y. Wang United Kingdom 6 179 1.1× 141 1.5× 80 1.1× 99 1.6× 47 1.3× 8 344
Marco Biondini France 9 156 1.0× 86 0.9× 134 1.9× 29 0.5× 40 1.1× 11 323
Kun Mi China 11 152 0.9× 117 1.3× 51 0.7× 66 1.1× 62 1.8× 19 355
Dan Tse United States 9 184 1.1× 70 0.8× 75 1.0× 52 0.9× 28 0.8× 16 321
Xian-Zi Yang China 8 225 1.4× 95 1.0× 30 0.4× 95 1.6× 17 0.5× 8 320
Alice Boissard France 10 171 1.1× 83 0.9× 38 0.5× 74 1.2× 27 0.8× 21 301
Li Gong China 8 161 1.0× 64 0.7× 30 0.4× 49 0.8× 25 0.7× 23 266
Allison M.L. Nixon Canada 6 204 1.3× 161 1.7× 38 0.5× 43 0.7× 14 0.4× 6 316
Jessica L. Weatherbee United States 3 179 1.1× 76 0.8× 52 0.7× 63 1.1× 40 1.1× 4 302
Sanne M. van Neerven Netherlands 9 151 0.9× 126 1.4× 58 0.8× 73 1.2× 35 1.0× 19 299

Countries citing papers authored by Pavla Bouchalová

Since Specialization
Citations

This map shows the geographic impact of Pavla Bouchalová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavla Bouchalová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavla Bouchalová more than expected).

Fields of papers citing papers by Pavla Bouchalová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavla Bouchalová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavla Bouchalová. The network helps show where Pavla Bouchalová may publish in the future.

Co-authorship network of co-authors of Pavla Bouchalová

This figure shows the co-authorship network connecting the top 25 collaborators of Pavla Bouchalová. A scholar is included among the top collaborators of Pavla Bouchalová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavla Bouchalová. Pavla Bouchalová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bouchalová, Pavla, et al.. (2024). A hybrid DDA/DIA-PASEF based assay library for a deep proteotyping of triple-negative breast cancer. Scientific Data. 11(1). 794–794. 3 indexed citations
2.
Bouchalová, Pavla, et al.. (2023). Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer. Scientific Reports. 13(1). 1285–1285. 10 indexed citations
3.
Šulc, Petr, et al.. (2023). Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide. Cellular & Molecular Biology Letters. 28(1). 68–68. 5 indexed citations
4.
Bouchalová, Pavla & Pavel Bouchal. (2022). Current methods for studying metastatic potential of tumor cells. Cancer Cell International. 22(1). 394–394. 47 indexed citations
5.
Bouchalová, Pavla, et al.. (2021). Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment. Biomedicines. 9(9). 1145–1145. 5 indexed citations
6.
Bouchalová, Pavla, Lucia Sommerová, David Potěšil, et al.. (2021). Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells. Molecular & Cellular Proteomics. 21(2). 100188–100188. 16 indexed citations
7.
Bouchalová, Pavla, David Potěšil, Milan Hora, et al.. (2021). A large‐scale assay library for targeted protein quantification in renal cell carcinoma tissues. PROTEOMICS. 22(7). e2100228–e2100228. 1 indexed citations
8.
Dvořáková, Monika, et al.. (2020). Transgelin Silencing Induces Different Processes in Different Breast Cancer Cell Lines. PROTEOMICS. 20(7). e1900383–e1900383. 4 indexed citations
9.
Farka, Zdeněk, Matthias J. Mickert, Zuzana Mikušová, et al.. (2020). Surface design of photon-upconversion nanoparticles for high-contrast immunocytochemistry. Nanoscale. 12(15). 8303–8313. 24 indexed citations
10.
Sommerová, Lucia, Pavla Bouchalová, Eva Jandáková, et al.. (2019). The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions. Antiviral Research. 163. 185–192. 17 indexed citations
11.
Faktor, Jakub, Lucia Knopfová, Pavla Bouchalová, et al.. (2019). Proteomics Identification and Validation of Desmocollin‐1 and Catechol‐O‐Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis. PROTEOMICS. 19(21-22). e1900073–e1900073. 7 indexed citations
12.
Hrstka, Roman, Pavla Bouchalová, Eva Michalová, et al.. (2015). AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway. Molecular Oncology. 10(5). 652–662. 44 indexed citations
13.
Bouchalová, Pavla, Rudolf Nenutil, Petr Müller, et al.. (2014). Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status. The Journal of Pathology. 233(3). 238–246. 20 indexed citations
14.
Nekulová, Marta, Jitka Holčáková, Rudolf Nenutil, et al.. (2013). Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(3). 415–425. 33 indexed citations
15.
MacLaine, Nicola J., Caroline O. Michie, Pavla Bouchalová, et al.. (2012). Anterior Gradient-3: A novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. Journal of Immunological Methods. 378(1-2). 20–32. 42 indexed citations
16.
Bouchalová, Pavla, et al.. (1978). Substituent and solvent effects in alkaline hydrolysis of thioamides. Collection of Czechoslovak Chemical Communications. 43(9). 2283–2288. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026